Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

Low grade gliomas (LGGs) of pineal region are usually difficult to remove and they frequently relapse or progress after front line chemotherapy. Bevacizumab-Irinotecan (BEVIRI) combination has been successfully attempted in children with recurrent LGGs, in most cases not previously irradiated. The e...

Full description

Bibliographic Details
Main Authors: Barbara Castelli, Carla Fonte, Milena Guidi, Marco Tellini, Marco Di Nicola, Alessandro Iacono, Anna Maria Buccoliero, Daniela Greto, Lorenzo Genitori, Iacopo Sardi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
low-grade gliomas
bevacizumab
irinotecan
pilocytic astrocytoma
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1244628/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1244628/full

Similar Items